Hospitals

Fudan University Shanghai Cancer Center (FUSCC) is China's earliest established oncology hospital and Shanghai's only tertiary Grade A hospital dedicated exclusively to cancer. The pancreatic surgery department, led by Prof. Yu Xianjun (虞先濬) and Dr. Xu Xiaowu (徐晓武), is a national leader in minimally invasive pancreatic surgery.

Pancreatic Surgery Highlights

• Over 1,000 Whipple procedures per year — among the highest volumes globally
• 80%+ minimally invasive rate (laparoscopic and robotic)
• 20%+ of cases involve vascular resection & reconstruction — demonstrating mastery of complex cases
• Live-streamed laparoscopic Whipple demonstrations at the 36th Italian Digestive Surgery Congress (Milan, 2025), earning international praise as "textbook-level"
• Innovated "middle approach laparoscopic Whipple" (Leave the Vein Alone concept) — reducing blood loss and complications
• Pancreatic duct-mucosa double-layer anastomosis technique for safer reconstruction

Equipment & Technology

• Da Vinci surgical robot system
• Proton and heavy ion therapy (integrated with Shanghai Proton and Heavy Ion Center)
• PET-CT, PET-MR, 5.0T MRI — 22 high-end imaging devices
• National drug clinical trial institution — hundreds of active oncology trials
• AI-powered precision oncology platform

Clinical Trials & Innovation

• 695 new clinical trials in 2025 alone (75% investigator-initiated)
• National Natural Science Foundation: 100 projects funded in 2025
• Published 35 papers with IF ≥ 20 in top journals including BMJ and Nature
• Clinical research funding: ~600M RMB/year
• 17 international guideline changes per year — shaping global oncology standards

International Recognition

• Cooperation agreements with 10+ institutions in France, Italy, Japan, Russia, Singapore
• Top A rating in national hospital performance for oncology — consistently
• Sister department relationship with UM/Sylvester Comprehensive Cancer Center (Miami)

Ruijin Hospital is home to the world's largest, fully integrated, one-stop pancreatic disease diagnosis and treatment center. Led by Prof. Shen Baiyong (沈柏用), Vice President of Ruijin Hospital and Director of the Pancreatic Disease Center, the center has treated over 30,000 pancreatic cancer cases — the largest quantity in the world.

Key Achievements

• 5-year survival rate of 21.2% — nearly double the global average of 9–12%
• Stage I 5-year survival: 35.3% — a new global benchmark
• Over 3,000 Da Vinci robotic pancreatic surgeries completed (malignant tumors: 2,000+)
• Prof. Shen: first and only Chinese expert to co-author the ESMO Asia-Pacific Pancreatic Cancer Consensus
• 12 high-risk biomarkers monitored — 3–6 month early warning window for tumor detection
• Personalized pancreatic cancer vaccine in Phase III clinical trials

International Partnership

In 2025, Ruijin established the Ruijin · United Family International Pancreatic Center in partnership with United Family Healthcare — an international medical platform explicitly designed to serve global patients. The partnership connects Ruijin's clinical excellence with international healthcare networks across the UK, UAE, and beyond.

MDT Model

The center integrates pancreatic surgery, medical oncology, ICU, interventional radiology, endoscopy, pathology, and precision medicine into a single multidisciplinary team — the same model used by top Western cancer centers.

Huashan Hospital is one of Fudan University's flagship teaching hospitals with strong general surgery and growing pancreatic expertise. The hospital's international department provides dedicated services for overseas patients.

Why Consider Huashan

• Strong general surgery department with hepatobiliary-pancreatic capabilities
• International patient ward with English-speaking coordinators
• Part of the Fudan University hospital system — cross-referral with Fudan Cancer Center available
• Well-established infrastructure for international patients

Changhai Hospital, affiliated with the Naval Medical University (formerly Second Military Medical University), has a strong hepatobiliary-pancreatic surgery department with high surgical volumes.

Why Consider Changhai

• High-volume hepatobiliary and pancreatic surgery
• Military-affiliated hospital with strict quality standards
• International patients can access services with appropriate coordination
• Strong academic research program in hepato-pancreato-biliary surgery

Shanghai First People's Hospital (Shanghai General Hospital) operates a dedicated pancreatic center as part of its surgical oncology program. The hospital is affiliated with Shanghai Jiao Tong University.

Why Consider Shanghai First People's

• Dedicated pancreatic center — not just a department within general surgery
• University-affiliated with strong research capabilities
• Growing international patient services